From: Betsy Zucker
Sent: Friday, July 16, 2021 10:31 AM
Subject: Article on Wyden & plans for improvement in Medicare
Keep the pressure on for drug price negotiation & Medicare expansion!
From this article:
“Meanwhile, a report this month from the House Oversight and Reform Committee found the 14 leading drug companies spent $577 billion on stock buybacks and dividends between 2016 and 2020: $56 million more than what they spent on research in that timeframe. At that rate, they’re slated to spend $1.15 trillion on buybacks and dividends between 2020 and 2029.”